MNKD (STOCKS)
Mannkind Corporation
$3.770500
-0.079500 (-2.06%)
Prev close: $3.850000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Michael E. Castagna
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,218.39M
- Employees
- 407
- P/E (TTM)
- -27.17
- P/B (TTM)
- -17.76
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
8
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.06 | $0.00 | -0.0585 | -3,900.00% |
|
Mar 2026 (Q1)
|
$-0.05 | $0.00 | -0.0485 | -3,233.33% |
|
Dec 2025 (Q4)
|
$-0.05 | $0.01 | -0.0647 | -440.14% |
|
Sep 2025 (Q3)
|
$0.07 | $0.02 | +0.0451 | +205.94% |
Financial Statements
| Revenues | $393.63M |
| Benefits Costs and Expenses | $442.28M |
| Cost Of Revenue | $40.34M |
| Costs And Expenses | $384.44M |
| Gross Profit | $353.29M |
| Nonoperating Income/Loss | -$57.85M |
| Operating Expenses | $82.92M |
| Selling, General, and Administrative Expenses | $199.89M |
| Depreciation and Amortization | $20.87M |
| Operating Income/Loss | $9.19M |
| Income/Loss From Continuing Operations After Tax | -$43.61M |
| Income/Loss From Continuing Operations Before Tax | -$48.65M |
| Income Tax Expense/Benefit | -$5.04M |
| Interest Expense, Operating | $9.51M |
| Net Income/Loss | -$43.61M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$43.61M |
| Net Income/Loss Available To Common Stockholders, Basic | -$43.61M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.14 |
| Diluted Earnings Per Share | -$0.14 |
| Basic Average Shares | 616,084,000 |
| Diluted Average Shares | 621,143,000 |
| Assets | $732.30M |
| Current Assets | $245.71M |
| Inventory | $44.42M |
| Other Current Assets | $201.29M |
| Noncurrent Assets | $486.59M |
| Fixed Assets | $85.16M |
| Intangible Assets | $4.98M |
| Other Non-current Assets | $396.46M |
| Liabilities | $799.50M |
| Current Liabilities | $142.90M |
| Accounts Payable | $11.04M |
| Wages | $19.02M |
| Other Current Liabilities | $112.84M |
| Noncurrent Liabilities | $656.60M |
| Long-term Debt | $319.09M |
| Other Non-current Liabilities | $337.52M |
| Equity | -$67.20M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$67.20M |
| Liabilities And Equity | $732.30M |
| Net Cash Flow From Operating Activities | -$8.05M |
| Net Cash Flow From Operating Activities, Continuing | -$8.05M |
| Net Cash Flow From Investing Activities | -$280.39M |
| Net Cash Flow From Investing Activities, Continuing | -$280.39M |
| Net Cash Flow From Financing Activities | $284.37M |
| Net Cash Flow From Financing Activities, Continuing | $284.37M |
| Net Cash Flow | -$4.07M |
| Net Cash Flow, Continuing | -$4.07M |
| Comprehensive Income/Loss | -$44.89M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$44.89M |
| Other Comprehensive Income/Loss | $6.71M |